Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China flag China · Delayed Price · Currency is CNY
6.48
+0.03 (0.47%)
Nov 13, 2026, 3:04 PM CST

Shanghai Kinetic Medical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
268.88134.89-105.57112.54-21.28161.78
Depreciation & Amortization
67.0667.0669.5265.8360.956.81
Other Amortization
14.5314.5312.9312.1613.3811.81
Loss (Gain) From Sale of Assets
-0.26-0.260.10.370.21-1.6
Asset Writedown & Restructuring Costs
0.380.382.910.58200149.4
Loss (Gain) From Sale of Investments
-82.83-82.83193.26-30.6328.9-47.79
Provision & Write-off of Bad Debts
----8.9619.6611.5
Other Operating Activities
-47.9944.6532.6723.3811.8538.82
Change in Accounts Receivable
13.8713.87-60.96-214.81149.9345.61
Change in Inventory
-13.82-13.82-29.1-21.89-49.65-60.62
Change in Accounts Payable
11.6411.6467.22336.82-174.1838.11
Change in Other Net Operating Assets
5.625.622.38---26.98
Operating Cash Flow
230.44189.09157.75274.26236.76378.16
Operating Cash Flow Growth
26.66%19.86%-42.48%15.84%-37.39%32.72%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-21.75-66.2-82.84-53.79-41.45-49.21
Sale of Property, Plant & Equipment
4.594.580.290.490.844.87
Cash Acquisitions
8.62-----64.73
Divestitures
145.4155.33-9.371.430.5
Investment in Securities
-326.47-430.08-509.42-168.58-132.14-37.69
Other Investing Activities
168.7370.9169.6411.858.597.04
Investing Cash Flow
-22.95-267.53-522.33-186.67-163.78-109.22

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-225.67310.26175.7172.82293.08
Long-Term Debt Repaid
--239.45-196.97-346.01-215.42-456.71
Lease Payments
-20.57-20.57-22.42-19.41-17.62-15.28
Net Debt Issued (Repaid)
-19.91-13.79113.29-170.31-42.6-163.62
Common Dividends Paid
-72.75-4.6-46.14-5.11-47.23-54.86
Other Financing Activities
11.8414.622.71-1.49-14.26-20.47
Financing Cash Flow
-80.82-3.7769.86-176.91-104.09-238.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-7.74-3.630.851.6711.97-3.03
Net Cash Flow
118.93-85.83-293.87-87.64-19.1426.96

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
208.69122.8874.91220.47195.3328.94
Free Cash Flow Growth
112.28%64.04%-66.02%12.89%-40.63%28.84%
Free Cash Flow Margin
28.43%12.76%7.61%23.06%16.75%25.93%
Free Cash Flow Per Share
0.290.170.100.310.270.46
Levered Free Cash Flow
218.82109.4355.1190.28160.13-135.88
Unlevered Free Cash Flow
219.39114.159.27194.38168.96-121.71
Free Cash Flow After Leases
188.12102.3252.49201.06177.68313.67

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
1.331.330.540.180.852.31
Cash Income Tax Paid
39.6147.3836.1763.87131.29123.06
Change in Working Capital
10.6710.67-48.0698.99-76.86-2.57